ID
13646
Description
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01423890
Link
https://clinicaltrials.gov/show/NCT01423890
Keywords
Versions (1)
- 2/22/16 2/22/16 -
Uploaded on
February 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT01423890
Eligibility Breast Cancer NCT01423890
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
axillary lymph node positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0677929
Description
advanced breast cancer inoperable
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3495917
- UMLS CUI [1,2]
- C0205187
Description
metastatic breast cancer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0036525
- UMLS CUI [1,2]
- C0678222
Description
her2 positive
Data type
boolean
Alias
- UMLS CUI [1]
- C1960398
Description
compliance
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
Description
informed consent
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Breast Cancer NCT01423890
- StudyEvent: Eligibility
C0193867 (UMLS CUI [2])
C1513276 (UMLS CUI [2])
C0677850 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
C0205187 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])